Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 234

1.

Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.

Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, Wehrens XH, Deswal A.

J Am Coll Cardiol. 2012 Mar 13;59(11):998-1005. doi: 10.1016/j.jacc.2011.11.040.

PMID:
22402071
[PubMed - indexed for MEDLINE]
Free Article
2.

Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.

Bavishi C, Ather S, Bambhroliya A, Jneid H, Virani SS, Bozkurt B, Deswal A.

Am J Cardiol. 2014 Jun 1;113(11):1834-8. doi: 10.1016/j.amjcard.2014.03.017. Epub 2014 Mar 18.

PMID:
24837261
[PubMed - indexed for MEDLINE]
3.

Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.

Maeder MT, Kaye DM.

Int J Cardiol. 2012 Mar 8;155(2):249-56. doi: 10.1016/j.ijcard.2010.10.007. Epub 2010 Oct 28.

PMID:
21035207
[PubMed - indexed for MEDLINE]
4.

Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.

Schwartzenberg S, Redfield MM, From AM, Sorajja P, Nishimura RA, Borlaug BA.

J Am Coll Cardiol. 2012 Jan 31;59(5):442-51. doi: 10.1016/j.jacc.2011.09.062.

PMID:
22281246
[PubMed - indexed for MEDLINE]
Free Article
5.

Mode of death in patients with heart failure and reduced vs. preserved ejection fraction: report from the registry of hospitalized heart failure patients.

Hamaguchi S, Kinugawa S, Sobirin MA, Goto D, Tsuchihashi-Makaya M, Yamada S, Yokoshiki H, Tsutsui H; JCARE-CARD Investigators.

Circ J. 2012;76(7):1662-9. Epub 2012 Apr 6.

PMID:
22481105
[PubMed - indexed for MEDLINE]
Free Article
6.

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction.

Edelmann F, Stahrenberg R, Gelbrich G, Durstewitz K, Angermann CE, Düngen HD, Scheffold T, Zugck C, Maisch B, Regitz-Zagrosek V, Hasenfuss G, Pieske BM, Wachter R.

Clin Res Cardiol. 2011 Sep;100(9):755-64. doi: 10.1007/s00392-011-0305-4. Epub 2011 Mar 17.

PMID:
21416189
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction.

Kato N, Kinugawa K, Shiga T, Hatano M, Takeda N, Imai Y, Watanabe M, Yao A, Hirata Y, Kazuma K, Nagai R.

J Cardiol. 2012 Jul;60(1):23-30. doi: 10.1016/j.jjcc.2012.01.010. Epub 2012 Mar 21.

PMID:
22445598
[PubMed - indexed for MEDLINE]
Free Article
8.

Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, Farber MA, Ford CE, Levy D, Massie BM, Nawaz S; ALLHAT Collaborative Research Group.

Circulation. 2008 Nov 25;118(22):2259-67. doi: 10.1161/CIRCULATIONAHA.107.762229. Epub 2008 Nov 10.

PMID:
19001024
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Heart failure with preserved ejection fraction and systolic dysfunction in the community.

Moutinho MA, Colucci FA, Alcoforado V, Tavares LR, Rachid MB, Rosa ML, Ribeiro ML, Abdalah R, Garcia JL, Mesquita ET.

Arq Bras Cardiol. 2008 Feb;90(2):132-7. English, Portuguese.

PMID:
18392386
[PubMed - indexed for MEDLINE]
Free Article
10.

Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.

Quiroz R, Doros G, Shaw P, Liang CS, Gauthier DF, Sam F.

Am J Cardiol. 2014 Feb 15;113(4):691-6. doi: 10.1016/j.amjcard.2013.11.014. Epub 2013 Nov 23.

PMID:
24484862
[PubMed - indexed for MEDLINE]
11.

Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) study.

Gupta DK, Shah AM, Castagno D, Takeuchi M, Loehr LR, Fox ER, Butler KR, Mosley TH, Kitzman DW, Solomon SD.

JACC Heart Fail. 2013 Apr;1(2):156-63.

PMID:
23671819
[PubMed - in process]
Free PMC Article
12.

Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure.

Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, Wu AW.

J Am Coll Cardiol. 2003 Oct 1;42(7):1226-33.

PMID:
14522486
[PubMed - indexed for MEDLINE]
Free Article
13.

Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute.

Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, Tu JV, Levy D.

Circulation. 2009 Jun 23;119(24):3070-7. doi: 10.1161/CIRCULATIONAHA.108.815944. Epub 2009 Jun 8.

PMID:
19506115
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Prognostic impact of myocardial interstitial fibrosis in non-ischemic heart failure. -Comparison between preserved and reduced ejection fraction heart failure.-.

Aoki T, Fukumoto Y, Sugimura K, Oikawa M, Satoh K, Nakano M, Nakayama M, Shimokawa H.

Circ J. 2011;75(11):2605-13. Epub 2011 Aug 6.

PMID:
21821961
[PubMed - indexed for MEDLINE]
Free Article
15.

Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.

Verbrugge FH, Duchenne J, Bertrand PB, Dupont M, Tang WH, Mullens W.

Am J Cardiol. 2013 Dec 15;112(12):1913-20. doi: 10.1016/j.amjcard.2013.08.013.

PMID:
24286620
[PubMed - indexed for MEDLINE]
16.

Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.

van Heerebeek L, Hamdani N, Falcão-Pires I, Leite-Moreira AF, Begieneman MP, Bronzwaer JG, van der Velden J, Stienen GJ, Laarman GJ, Somsen A, Verheugt FW, Niessen HW, Paulus WJ.

Circulation. 2012 Aug 14;126(7):830-9. doi: 10.1161/CIRCULATIONAHA.111.076075. Epub 2012 Jul 17.

PMID:
22806632
[PubMed - indexed for MEDLINE]
Free Article
17.

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.

Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van Gilst WH.

Eur Heart J. 2013 May;34(19):1424-31. doi: 10.1093/eurheartj/eht066. Epub 2013 Mar 6.

PMID:
23470495
[PubMed - indexed for MEDLINE]
Free Article
18.

Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction.

Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, Levy D.

Circ Heart Fail. 2013 Mar;6(2):279-86. doi: 10.1161/CIRCHEARTFAILURE.112.972828. Epub 2012 Dec 27.

PMID:
23271790
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Prognostic significance of applying the European Society of Cardiology consensus algorithm for heart failure with preserved systolic function diagnosis.

Almeida P, Rodrigues J, Lourenço P, Maciel MJ, Bettencourt P.

Clin Cardiol. 2012 Dec;35(12):770-6. doi: 10.1002/clc.22044. Epub 2012 Aug 9.

PMID:
22886726
[PubMed - indexed for MEDLINE]
20.

Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study.

Rickenbacher P, Pfisterer M, Burkard T, Kiowski W, Follath F, Burckhardt D, Schindler R, Brunner-La Rocca HP; TIME-CHF Investigators.

Eur J Heart Fail. 2012 Nov;14(11):1218-29. doi: 10.1093/eurjhf/hfs113. Epub 2012 Jul 6.

PMID:
22771846
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk